Health And Medicine

In recognition of Alcohol Awareness Month, the School of Medicine Basic Sciences will host a conversation between Will Welch, global editorial director of "GQ" magazine, and the Vanderbilt Center for Addiction Research on Wednesday, April 21, from 11 a.m. to noon CT. Read More

Gregor Neuert has discovered that cells respond differently to acute and gradual stress. This finding will transform how cell signaling is understood and inform the drug discovery processes. Read More

While populations’ access to health care is crucial to combating the spread of COVID-19, a team of Vanderbilt researchers has found that understanding the cultural context of health within a community is an equally significant factor—and can help leaders better prepare for future crises. Read More

Dr. James E. Crowe Jr., a physician-scientist on the front lines of global research to eliminate human susceptibility to COVID-19 and other illnesses, is Vanderbilt University’s winner of the 2021 Southeastern Conference Faculty Achievement Award. Read More

Triple-negative breast cancer cells engage in a “glutamine steal” — outcompeting T cells for the nutrient glutamine and impairing their ability to kill tumor cells, Vanderbilt researchers have discovered. Read More

The summer 2021 Artist in Residence program applications are now open to all undergraduate students nationwide. Applications submitted online will be accepted until April 2. The residency is facilitated by the Vanderbilt Institute for Infection, Immunology and Inflammation. Read More

More than 60 Vanderbilt students, staff and faculty members helped Nashville’s Metro Public Health Department vaccinate more than 10,000 community members in a marathon, 14-hour event on March 20. Read More

Vanderbilt University School of Nursing is joining fellow Tennessee school University of the South and more than 100 universities in 50 countries around the world to focus on a critical question: What can be done to help solve climate change while supporting struggling communities that have faced joblessness, sickness and loss? On Thursday, April 8,... Read More

In recognition of Colorectal Cancer Awareness Month, the School of Medicine Basic Sciences will host a panel discussion, "On the Cutting Edge: Research Toward a Cure for Colorectal Cancer,” on Tuesday, March 30, from 11 a.m. to noon CT. Read More

The remarkable success of the COVID-19 vaccines began in a Vanderbilt lab decades ago, with the groundbreaking research of alumnus Dr. Barney Graham. Read More

The Vanderbilt Institute of Chemical Biology’s 500th seminar speaker will be award-winning biochemist, inventor and educator Michael Marletta. His talk will take place on Wednesday, March 24, at 12:15 p.m. CT, when he will discuss the vitality and toxicity of nitric oxide in the body. Read More

The U.S. Centers for Disease Control and Prevention (CDC) has awarded Vanderbilt University Medical Center a two-year, $3.7-million contract to determine genetic and bacterial factors that may increase the risk for severe illness and death from COVID-19. Read More

A novel hormone deficiency may exist in humans, Vanderbilt investigators have discovered. In an analysis of two decades worth of electronic health records, the researchers found that some patients have unexpectedly low levels of natriuretic peptide hormone in clinical situations that should cause high levels of the hormone. Read More

A new genome-wide CRISPR screening technique conducted by researchers at Vanderbilt University is offering new insights about how tumors in 80 to 90 percent of all cancers grow. Read More

Strong, collaborative relationships with principal investigators are a key factor of longevity in clinical research coordinator positions — an essential, but increasingly transient job in executing treatment-advancing clinical trials, Vanderbilt University Medical Center researchers found. Read More

Men’s health across Tennessee is trending toward improvement, according to the 2020 Tennessee Men’s Health Report Card, but racial and geographic disparities persist. The report card is compiled by Vanderbilt’s Center for Research on Men’s Health in cooperation with Vanderbilt University Medical Center, the Tennessee Department of Health, Meharry Medical College and the Tennessee Men’s Health Network. Read More

The emergence of pathogenic skin fungi that cause the disease chytridiomycosis is contributing to the global loss of amphibian populations.  Read More

A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine.... Read More

David DeMets, PhD, known for his work on statistical methods to monitor interim clinical trial data for early evidence of benefit or harm, will deliver the next web-based Discovery Lecture. Read More

Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center. Read More